Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-11-07 4:25 pm Unchanged |
2022-11-03 | 13D | Keros Therapeutics, Inc. KROS |
ORBIMED ADVISORS LLC | 1,268,734 4.600% |
0 (Unchanged) |
Filing History |
| 2022-09-28 4:23 pm Purchase |
2022-09-19 | 13D | Third Harmonic Bio, Inc. THRD |
ORBIMED ADVISORS LLC | 5,779,071 14.300% |
5,779,071 (New Position) |
Filing History |
| 2022-09-27 4:29 pm Sale |
2022-09-23 | 13D | Alpine Immune Sciences, Inc. ALPN |
ORBIMED ADVISORS LLC | 4,081,592 9.300% |
-145,251 (-3.44%) |
Filing History |
| 2022-09-16 4:23 pm Purchase |
2022-09-16 | 13D | Edgewise Therapeutics, Inc. EWTX |
ORBIMED ADVISORS LLC | 14,301,551 23.300% |
622,496 (+4.55%) |
Filing History |
| 2022-09-14 4:34 pm Sale |
2022-09-12 | 13D | SpringWorks Therapeutics, Inc. SWTX |
ORBIMED ADVISORS LLC | 5,599,842 9.300% |
-586,465 (-9.48%) |
Filing History |
| 2022-08-30 4:37 pm Purchase |
2022-08-26 | 13D | Xtant Medical Holdings, Inc. XTNT |
ORBIMED ADVISORS LLC | 73,114,592 67.900% |
241,098 (+0.33%) |
Filing History |
| 2022-08-26 4:12 pm Sale |
2022-08-24 | 13D | Arcutis Biotherapeutics, Inc. ARQT |
ORBIMED ADVISORS LLC | 2,828,356 4.700% |
-318,368 (-10.12%) |
Filing History |
| 2022-08-19 4:17 pm Unchanged |
2022-08-18 | 13D | TELA Bio, Inc. TELA |
ORBIMED ADVISORS LLC | 3,058,267 16.500% |
0 (Unchanged) |
Filing History |
| 2022-08-18 4:39 pm Purchase |
2022-08-16 | 13D | Terns Pharmaceuticals, Inc. TERN |
ORBIMED ADVISORS LLC | 7,481,204 19.900% |
3,690,000 (+97.33%) |
Filing History |
| 2022-08-12 2:29 pm Purchase |
2022-08-10 | 13D | 89bio, Inc. ETNB |
ORBIMED ADVISORS LLC | 5,028,174 6.900% |
5,028,174 (New Position) |
Filing History |
| 2022-08-08 4:26 pm Sale |
2022-08-04 | 13D | Arcutis Biotherapeutics, Inc. ARQT |
ORBIMED ADVISORS LLC | 3,146,724 5.400% |
-387,813 (-10.97%) |
Filing History |
| 2022-07-05 4:30 pm Sale |
2022-07-05 | 13D | 89bio, Inc. ETNB |
ORBIMED ADVISORS LLC | 1,829,436 4.700% |
-35,285 (-1.89%) |
Filing History |
| 2022-06-28 4:22 pm Sale |
2022-06-24 | 13D | Arcutis Biotherapeutics, Inc. ARQT |
ORBIMED ADVISORS LLC | 3,534,537 6.900% |
-306,027 (-7.97%) |
Filing History |
| 2022-05-05 4:56 pm Purchase |
2022-05-03 | 13D | Passage Bio, Inc. PASG |
ORBIMED ADVISORS LLC | 6,841,423 12.600% |
894,100 (+15.03%) |
Filing History |
| 2022-04-08 5:20 pm Sale |
2022-04-06 | 13D | Arcutis Biotherapeutics, Inc. ARQT |
ORBIMED ADVISORS LLC | 3,840,564 7.600% |
-427,000 (-10.01%) |
Filing History |
| 2022-04-01 5:06 pm Unchanged |
2022-03-29 | 13D | PMV Pharmaceuticals, Inc. PMVP |
ORBIMED ADVISORS LLC | 6,589,330 14.500% |
0 (Unchanged) |
Filing History |
| 2022-03-15 4:30 pm Unchanged |
2022-03-10 | 13D | Sierra Oncology, Inc. SRRA |
ORBIMED ADVISORS LLC | 3,044,753 12.200% |
0 (Unchanged) |
Filing History |
| 2022-02-11 5:09 pm Sale |
2021-12-31 | 13G | Xenon Pharmaceuticals Inc. XENE |
ORBIMED ADVISORS LLC | 631,000 1.220% |
-1,080,305 (-63.13%) |
Filing History |
| 2022-02-11 5:08 pm Purchase |
2021-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
ORBIMED ADVISORS LLC | 61,212 6.400% |
12 (+0.02%) |
Filing History |
| 2022-02-11 4:58 pm Purchase |
2021-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN |
ORBIMED ADVISORS LLC | 350,641 5.300% |
24,681 (+7.57%) |
Filing History |